The DOI matches its Crossref record; 455 of the 455 references it cites were found in a registry or an index.
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Open accessAbstract
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are among the most common opportunistic pathogens in nosocomial infections. ESKAPE pathogens distinguish themselves from normal ones by developing a high level of antibiotic resistance that involves multiple mechanisms. Contemporary therapeutic strategies which are potential options in combating ESKAPE bacteria need further investigation. Herein, a broad overview of the antimicrobial research on ESKAPE pathogens over the past five years is provided with prospective clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 455
Mbaveng, A. T., Sandjo, L. P., Tankeo, S. B., Ndifor, A. R., Ambassa, P., Nagdjui, B. T., & Kuete, V. (2015) · SpringerPlus · doi:10.1186/s40064-015-1645-8 · Cited by 122
Zamora, C. M. P., Torres, C. A., & Núñez, M. B. (2018) · Molecules · doi:10.3390/molecules23030544 · Cited by 122
Jansen, M., Wahida, A., Latz, S., Krüttgen, A., Häfner, H., Buhl, E. M., Ritter, K., & Horz, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-32344-y · Cited by 121
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-019-01067-3 · Cited by 120
Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
Khan, S. N., & Khan, A. U. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00174 · Cited by 119
Wang, G., Hanke, M. L., Mishra, B., Lushnikova, T., Heim, C. E., Thomas, V. C., Bayles, K. W., & Kielian, T. (2014) · ACS Chemical Biology · doi:10.1021/cb500475y · Cited by 119
Villano, S. A., Steenbergen, J. N., & Loh, E. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0100 · Cited by 119
François, B., Mercier, E., Gonzalez, C., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5229-2 · Cited by 119
Visualizing Attack of Escherichia coli by the Antimicrobial Peptide Human Defensin 5
Chileveru, H. R., Lim, S. A., Chairatana, P., Wommack, A. J., Chiang, I.-L., & Nolan, E. M. (2015) · Biochemistry · doi:10.1021/bi501483q · Cited by 115
Membrane destruction and phospholipid extraction by using two-dimensional MoS 2 nanosheets
Wu, R., Ou, X., Tian, R., Zhang, J., Jin, H., Dong, M., Li, J., & Liu, L. (2018) · Nanoscale · doi:10.1039/c8nr04207a · Cited by 115
Self-citationSharma, R., Park, T. E., & Moy, S. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.01.018 · Cited by 112
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections
Palavutitotai, N., Jitmuang, A., Tongsai, S., Kiratisin, P., & Angkasekwinai, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193431 · Cited by 112
Lara, B. G., Saucedo-Mora, M. Á., Roldán-Sánchez, J. A., Peréz-Eretza, B., Ramasamy, M., Lee, J., Coria‐Jiménez, R., Tapia, M. P., Varela-Guerrero, V., & García‐Contreras, R. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12456 · Cited by 110
Yin, D., Wu, S., Yang, Y., Shi, Q., Dong, D., Zhu, D., & Hu, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02431-18 · Cited by 110
Alatoom, A. A., Elsayed, H., Lawlor, K., AbdelWareth, L., El-Lababidi, R. M., Cardona, L., Mooty, M., Bonilla, M.-F., Nusair, A. R., & Mirza, I. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.06.007 · Cited by 109
Adhesive Pili in UTI Pathogenesis and Drug Development
Spaulding, C. N., & Hultgren, S. J. (2016) · Pathogens · doi:10.3390/pathogens5010030 · Cited by 108
Eugenol exhibits anti-virulence properties by competitively binding to quorum sensing receptors
Rathinam, P., Kumar, H. S. V., & Viswanathan, P. (2017) · Biofouling · doi:10.1080/08927014.2017.1350655 · Cited by 108
O’Riordan, W. D., McManus, A. J., Teras, J., Poromanski, I., Saldariagga, M. C., Quintas, M., Lawrence, L. E., Liang, S., Cammarata, S., PROCEED Study Group, et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy165 · Cited by 108
Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria
El‐Shibiny, A., & El-Sahhar, S. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0030 · Cited by 107
Sah, U., Sharma, K., Chaudhri, N., et al. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.046 · Cited by 107
Gashaw, M., Berhane, M., Bekele, S., Kibru, G., Teshager, L., Yilma, Y., Ahmed, Y., Fentahun, N., Asefa, H., Wieser, A., et al. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0431-0 · Cited by 107
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 106
Lu, C., Maurer, C. K., Kirsch, B., Steinbach, A., & Hartmann, R. W. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307547 · Cited by 105
Omosa, L. K., Midiwo, J. O., Mbaveng, A. T., Tankeo, S. B., Seukep, A. J., Voukeng, I. K., Dzotam, J. K., Isemeki, J., Derese, S., Omole, R. A., et al. (2016) · SpringerPlus · doi:10.1186/s40064-016-2599-1 · Cited by 105
Boucher, H. W., Ambrose, P. G., Chambers, H. F. “., Ebright, R. H., Jezek, A., Murray, B. E., Newland, J. G., Ostrowsky, B. E., Rex, J. H., & on behalf of the Infectious Diseases Society of America (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix211 · Cited by 105
Čiginskienė, A., Dambrauskienė, A., Rello, J., & Adukauskienė, D. (2019) · Medicina · doi:10.3390/medicina55020049 · Cited by 105
Pullman, J. R., Gardovskis, J., Farley, B., Sun, E., Quintas, M., Lawrence, L. E., Ling, R., Cammarata, S., & PROCEED Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx329 · Cited by 104
Functions of Cationic Host Defense Peptides in Immunity
Hemshekhar, M., Anaparti, V., & Mookherjee, N. (2016) · Pharmaceuticals · doi:10.3390/ph9030040 · Cited by 103
Synergistic antimicrobial effect of photodynamic therapy and ciprofloxacin
Ronqui, M. R., Coletti, T. M. S. F. D. A., de Freitas, L. M., Miranda, E. T., & Fontana, C. R. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.02.036 · Cited by 102
Voukeng, I. K., Beng, V. P., & Kuete, V. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1371-y · Cited by 102
Ackerman, D. L., Craft, K. M., Doster, R. S., Weitkamp, J.-H., Aronoff, D. M., Gaddy, J. A., & Townsend, S. D. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00183 · Cited by 102
Back to the future: bacteriophages as promising therapeutic tools
Domingo‐Calap, P., Georgel, P., & Bahram, S. (2016) · HLA · doi:10.1111/tan.12742 · Cited by 101
Compain, F., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-17 · Cited by 101
Oliva, A., Costantini, S., Angelis, M. D., Garzoli, S., Božović, M., Mascellino, M. T., Vullo, V., & Ragno, R. (2018) · Molecules · doi:10.3390/molecules23102584 · Cited by 101
Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway
Park, S. R., Tripathi, A., Wu, J., Schultz, P. J., Yim, I., McQuade, T. J., Yu, F., Arewång, C.-J., Mensah, A. Y., Tamayo‐Castillo, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10710 · Cited by 100
Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections
Brown, P., & Dawson, M. J. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.146 · Cited by 99
Plazomicin: A Next‐Generation Aminoglycoside
Shaeer, K. M., Zmarlicka, M. T., Chahine, E. B., et al. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2203 · Cited by 99
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Eljaaly, K., Alharbi, A., Alshehri, S., Ortwine, J. K., & Pogue, J. M. (2019) · Drugs · doi:10.1007/s40265-019-1054-3 · Cited by 99
Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections
Younis, W., Thangamani, S., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150506154434 · Cited by 99
The antibiotic pipeline: reviving research and development and speeding drugs to market
Luepke, K. H., & Mohr, J. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1308251 · Cited by 98
Lacoma, A., Cano, V., Moranta, D., Regueiro, V., Domínguez‐Villanueva, D., Laabei, M., González-Nicolau, M., Ausina, V., Prat, C., & Bengoechea, J. A. (2017) · Virulence · doi:10.1080/21505594.2017.1361089 · Cited by 98
Ansari, M. A., Khan, H. M., Khan, A. A., Cameotra, S. S., Saquib, Q., & Musarrat, J. (2014) · Journal of Basic Microbiology · doi:10.1002/jobm.201300748 · Cited by 97
Is Quorum Sensing Interference a Viable Alternative to Treat Pseudomonas aeruginosa Infections?
García‐Contreras, R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01454 · Cited by 97
Wu, X., Tan, S., Xing, Y., Pu, Q., Wu, M., & Zhao, J. X. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.05.024 · Cited by 97
Artini, M., Patsilinakos, A., Papa, R., Božović, M., Sabatino, M., Garzoli, S., Vrenna, G., Tilotta, M., Pepi, F., Ragno, R., et al. (2018) · Molecules · doi:10.3390/molecules23020482 · Cited by 97
Upreti, N., Rayamajhee, B., Sherchan, S. P., Choudhari, M. K., & Banjara, M. R. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0408-z · Cited by 97
Schütz, C., & Empting, M. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.241 · Cited by 96
Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
Tiwari, V., Roy, R., & Tiwari, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00618 · Cited by 94
Novel approaches for the design and discovery of quorum-sensing inhibitors
Scutera, S., Zucca, M., & Savoia, D. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.894974 · Cited by 94
Chitosan nanoparticles loaded antibiotics as drug delivery biomaterial
Ibrahim, H., El-Bisi, M. K., Taha, G. M., & El-Alfy, E. A. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.501015 · Cited by 94
Leung, L. M., Fondrie, W. E., Doi, Y., Johnson, J. K., Strickland, D. K., Ernst, R. K., & Goodlett, D. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-04793-4 · Cited by 94
Antibacterial monoclonal antibodies: the next generation?
DiGiandomenico, A., & Sellman, B. R. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.014 · Cited by 93
A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity
Rabanal, F., Grau-Campistany, A., Vila‐Farrés, X., González-Linares, J., Borràs, M., Vilà, J., Manresa, Á., & Cajal, Y. (2015) · Scientific Reports · doi:10.1038/srep10558 · Cited by 93
Worthington, R. J., Blackledge, M. S., & Melander, C. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.58 · Cited by 93
Moran, G. J., Krishnadasan, A., Mower, W. R., Abrahamian, F. M., LoVecchio, F., Steele, M. T., Rothman, R. E., Karras, D. J., Hoagland, R. J., Pettibone, S., et al. (2017) · JAMA · doi:10.1001/jama.2017.5653 · Cited by 92
Real time detection of ESKAPE pathogens by a nitroreductase-triggered fluorescence turn-on probe
Xu, S., Wang, Q., Zhang, Q., Zhang, L., Zuo, L., Jiang, J., & Hu, H. (2017) · Chemical Communications · doi:10.1039/c7cc07050k · Cited by 92
Malekian, A., Djavid, G. E., Akbarzadeh, K., Soltandallal, M., Rassi, Y., Rafinejad, J., Foroushani, A. R., Farhoud, A. R., Bakhtiary, R., & Totonchi, M. (2019) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000000496 · Cited by 92
Babii, C., Bahrin, L. G., Neagu, A.-N., Gostin, I. N., Mihăşan, M., Birsa, M. L., & Ștefan, M. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13048 · Cited by 91
Bionano Interaction Study on Antimicrobial Star-Shaped Peptide Polymer Nanoparticles
Lam, S. J., Wong, E. H. H., O’brien-simpson, N. M., Pantarat, N., Blencowe, A., Reynolds, E. C., & Qiao, G. G. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11402 · Cited by 89
Antonova, N. P., Vasina, D. V., Lendel, A. M., Usachev, E. V., Makarov, V. V., Al, G., Петрович, Т. А., & Gushchin, V. А. (2019) · Viruses · doi:10.3390/v11030284 · Cited by 89
Bacteriophages and Their Immunological Applications against Infectious Threats
Criscuolo, E., Spadini, S., Lamanna, J., Ferro, M., & Burioni, R. (2017) · Journal of Immunology Research · doi:10.1155/2017/3780697 · Cited by 88
Farman, M., Yasir, M., Al-Hindi, R. R., Farraj, S. A., Jiman-Fatani, A. A., Alawi, M., & Azhar, E. I. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0508-4 · Cited by 88
Utegenova, G. A., Pallister, K. B., Kushnarenko, S. V., Özek, G., Özek, T., Abidkulova, K. T., Kirpotina, L. N., Schepetkin, I. A., Quinn, M. T., & Voyich, J. M. (2018) · Molecules · doi:10.3390/molecules23071679 · Cited by 87
Liposomal antibiotics for the treatment of infectious diseases
Alhariri, M., Azghani, A. O., & Omri, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.822860 · Cited by 86
Seedat, N., Kalhapure, R. S., Mocktar, C., Vepuri, S. B., Jadhav, M., Soliman, M. E. S., & Govender, T. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.053 · Cited by 86
New and improved? A review of novel antibiotics for Gram-positive bacteria
Abbas, M., Paul, M., & Huttner, A. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.010 · Cited by 86
Cefazolin loaded chitosan nanoparticles to cure multi drug resistant Gram-negative pathogens
Jamil, B., Habib, H., Abbasi, S. A., et al. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.09.078 · Cited by 85
Mother Knows Best: Deciphering the Antibacterial Properties of Human Milk Oligosaccharides
Craft, K. M., & Townsend, S. D. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00630 · Cited by 84
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Rello, J., Krenn, C.-G., Locker, G. J., Pilger, E., Madl, C., Balica, L., Dugernier, T., Laterre, P., Spapen, H. D., Depuydt, P. O., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1601-9 · Cited by 83
Mai, B., Gao, Y., Li, M., Wang, X., Zhang, K., Liu, Q., Xu, C., & Wang, P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138185 · Cited by 83
Khan, M. F., Tang, H., Lyles, J. T., Pineau, R. M., Mashwani, Z., & Quave, C. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00815 · Cited by 83
Nanoliposome-based antibacterial drug delivery
Hallaj‐Nezhadi, S., & Hassan, M. (2013) · Drug Delivery · doi:10.3109/10717544.2013.863409 · Cited by 81
Information Phage Therapy Research Should Report
Abedon, S. T. (2017) · Pharmaceuticals · doi:10.3390/ph10020043 · Cited by 81
Varshney, A. K., Kuzmicheva, G. A., Lin, J., Sunley, K. M., Bowling, R. A., Kwan, T.-Y., Mays, H. R., Rambhadran, A., Zhang, Y., Martin, R. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190537 · Cited by 80
Sonawane, S. J., Kalhapure, R. S., Rambharose, S., Mocktar, C., Vepuri, S. B., Soliman, M. E. S., & Govender, T. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.021 · Cited by 79
Sader, H. S., Castanheira, M., Huband, M. D., Jones, R. N., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-17 · Cited by 79
Suppression of Staphylococcus aureus virulence by a small-molecule compound
Gao, P., Ho, P., Yan, B., Sze, K. H., DAVIES, J. E., & Kao, R. Y. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720520115 · Cited by 78
Flume, P. A., VanDevanter, D. R., Morgan, E. E., Dudley, M. N., Loutit, J., Bell, S. C., Kerem, E., Fischer, R., Smyth, A. R., Aaron, S. D., et al. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.12.004 · Cited by 77
Grace, J. L., Huang, J. X., Cheah, S.-E., Truong, N. P., Cooper, M. A., Li, J., Davis, T. P., Quinn, J. F., Velkov, T., & Whittaker, M. R. (2016) · RSC Advances · doi:10.1039/c5ra24361k · Cited by 77
Self-citationKarlowsky, J. A., Kazmierczak, K. M., Bouchillon, S. K., DeJonge, B. L. M., Stone, G. G., & Sahm, D. F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01814-18 · Cited by 77
Garza‐González, E., Morfín‐Otero, R., Mendoza-Olazarán, S., Bocanegra‐Ibarias, P., Flores-Treviño, S., Rodríguez-Noriega, E., Ponce‐de‐León, A., Sánchez-Francia, D., Franco‐Cendejas, R., Arroyo‐Escalante, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209865 · Cited by 77
Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation
Yang, Z., Liu, J., Gao, J., Chen, S., & Huang, G. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.085 · Cited by 76
Naimi, H. M., Rasekh, H., Noori, A. Z., & Bahaduri, M. A. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2844-4 · Cited by 76
Bandara, N., Herpin, M. J., Kolacny, D., Harb, A., Romanovicz, D. K., & Smyth, H. D. C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00360 · Cited by 74
Lin, S. X. W., & Balthasar, J. P. (2018) · Antibodies · doi:10.3390/antib7010005 · Cited by 74
Benameur, Q., Gervasi, T., Pellizzeri, V., Pľuchtová, M., Tali-Maamar, H., Assaous, F., Guettou, B., Rahal, K., Gruľová, D., Dugo, G., et al. (2018) · Natural Product Research · doi:10.1080/14786419.2018.1466124 · Cited by 74
Banerjee, T., Mishra, A., Das, A., Sharma, S., Barman, H., & Yadav, G. (2018) · Journal of Pathogens · doi:10.1155/2018/9129083 · Cited by 74
Kaushik, A., Ammerman, N. C., Lee, J., Martins, O., Kreiswirth, B. N., Lamichhane, G., Parrish, N. M., & Nuermberger, E. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02623-18 · Cited by 74
Benefits and Challenges of Antivirulence Antimicrobials at the Dawn of the Post-Antibiotic Era
Totsika, M. (2016) · Drug Delivery Letters · doi:10.2174/2210303106666160506120057 · Cited by 73
Agarwal, R. K., Bartsch, S. M., Kelly, B. J., Prewitt, M., Liu, Y., Chen, Y., & Umscheid, C. A. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.028 · Cited by 73
Tohamy, S. T. K., Aboshanab, K., El‐Mahallawy, H. A., El‐Ansary, M. R., & Afifi, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s163293 · Cited by 73
Shirbin, S. J., Insua, I., Holden, J. A., Lenzo, J. C., Reynolds, E. C., O’brien-simpson, N. M., & Qiao, G. G. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800627 · Cited by 73
Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles
Jiang, L., Greene, M. K., Insua, J. L., Sá‐Pessoa, J., Small, D. M., Smyth, P., McCann, A. P., Cogo, F., Bengoechea, J. A., Taggart, C. C., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.040 · Cited by 72
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02327-17 · Cited by 71
Ramsamy, Y., Essack, S. Y., Sartorius, B. K. D., Patel, M., & Mlisana, K. P. (2018) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v7i2.887 · Cited by 71
Roca, A., Oluwalana, C., Bojang, A. L., Camara, B., Kampmann, B., Bailey, R. L., Demba, A., Bottomley, C., & D’Alessandro, U. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.005 · Cited by 70
Antimicrobial activity of nanoemulsion on drug-resistant bacterial pathogens
Krishnamoorthy, R., Athinarayanan, J., Periasamy, V. S., Adisa, A. R., Al-Shuniaber, M. A., Gassem, M. A., & Alshatwi, A. A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.04.035 · Cited by 70
McLeod, S. M., Shapiro, A. B., Moussa, S. H., Johnstone, M. R., McLaughlin, R. E., DeJonge, B. L. M., & Miller, A. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-17 · Cited by 69
Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections
Su, F., Chen, J., Son, H., Kelly, A. M., Convertine, A. J., West, T. E., Skerrett, S. J., Ratner, D. M., & Stayton, P. S. (2018) · Biomaterials Science · doi:10.1039/c8bm00282g · Cited by 68
Self-citationKarlowsky, J. A., Kazmierczak, K. M., Bouchillon, S. K., DeJonge, B. L. M., Stone, G. G., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02569-17 · Cited by 68
Photosensitizer-Embedded Polyacrylonitrile Nanofibers as Antimicrobial Non-Woven Textile
Stanley, S. L., Scholle, F., Zhu, J., Lu, Y., Zhang, X., Situ, X., & Ghiladi, R. A. (2016) · Nanomaterials · doi:10.3390/nano6040077 · Cited by 67
Tuon, F. F., Gavrilko, O., Almeida, S. D., Sumi, E. R., Alberto, T., Rocha, J. L., & Rosa, E. A. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.12.007 · Cited by 66
Stacy, D. M., Quement, S. T. L., Hansen, C. L., et al. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27155a · Cited by 66
Selvadoss, P. P., Nellore, J., Ravindrran, M. B., Sekar, U., & Tippabathani, J. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1307209 · Cited by 66
Antimicrobial peptide–metal ion interactions – a potential way of activity enhancement
Łoboda, D., Kozłowski, H., & Rowińska‐Żyrek, M. (2018) · New Journal of Chemistry · doi:10.1039/c7nj04709f · Cited by 66
Itaconimides as Novel Quorum Sensing Inhibitors of Pseudomonas aeruginosa
Fong, J., Mortensen, K. T., Nørskov, A., Qvortrup, K. M., Yang, L., Tan, C., Nielsen, T. E., & Givskov, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00443 · Cited by 66
Pharmaceutical and Toxicological Properties of Engineered Nanomaterials for Drug Delivery
Palombo, M. S., Deshmukh, M., Myers, D., Gao, J., Székely, Z., & Sinko, P. J. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134615 · Cited by 65
Frenck, R. W., Creech, C. B., Sheldon, E. A., Seiden, D., Kankam, M. K., Baber, J., Zito, E. T., Hubler, R., Eiden, J., Severs, J. M., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.010 · Cited by 65
Alalaiwe, A. S., Wang, P., Lu, P., Chen, Y.-P., Fang, J., & Yang, S.-C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01493 · Cited by 65
Magyarics, Z., Leslie, F., Bartko, J., Rouha, H., Luperchio, S. A., Schoergenhofer, C., Schwameis, M., Derhaschnig, U., Lagler, H., Stiebellehner, L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00350-19 · Cited by 65
Tabor, D. E., Yu, L., Mok, H., Tkaczyk, C., Sellman, B. R., Wu, Y., Oganesyan, V., Slidel, T. W. F., Jafri, H. S., McCarthy, M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00357-16 · Cited by 64
Eggers, S. I., Barker, A., Valentine, S., Hess, T., Duster, M. N., & Safdar, N. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3028-6 · Cited by 64
Baumann, T., Nickling, J. H., Bartholomae, M., Buivydas, A., Kuipers, O. P., & Budiša, N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00124 · Cited by 63
Rajasekharan, S. K., Ramesh, S., Satish, A. S., & Lee, J. (2017) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1609.09043 · Cited by 63
Rineh, A., Dolla, N. K., Ball, A. R., Magana, M., Bremner, J. B., Hamblin, M. R., Tegos, G. P., & Kelso, M. J. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00095 · Cited by 63
Craft, K. M., & Townsend, S. D. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00209 · Cited by 63
Liang, T., Leung, L. M., Opene, B. N. A., Fondrie, W. E., Lee, Y. I., Chandler, C. E., Yoon, S. H., Doi, Y., Ernst, R. K., & Goodlett, D. R. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02611 · Cited by 63
Woźniak, A., Rapacka-Zdończyk, A., Mutters, N. T., & Grinholc, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00229 · Cited by 63
Korczowski, B., Antadze, T., Giorgobiani, M., Stryjewski, M. E., Jandourek, A., Smith, A., O'Neal, T. S., & Bradley, J. S. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001191 · Cited by 62
The development of small-molecule modulators for ClpP protease activity
Ye, F., Li, J., & Yang, C. (2016) · Molecular BioSystems · doi:10.1039/c6mb00644b · Cited by 62
Self-citationAnti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting
Hsu, C., Yang, S.-C., Sung, C. T., Weng, Y.-H., & Fang, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s147226 · Cited by 62
Nissen, M. D., Marshall, H. S., Richmond, P., Shakib, S., Jiang, Q. L., Cooper, D., Rill, D., Baber, J., Eiden, J. J., Gruber, W. C., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.024 · Cited by 61
Defensin-based anti-infective strategies
Wilmes, M., & Sahl, H. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.08.007 · Cited by 60
Development of novel antibacterial drugs to combat multiple resistant organisms
Bassetti, M., & Righi, E. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-015-1280-4 · Cited by 60
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them
Hadjifrangiskou, M., & Brannon, J. R. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98939 · Cited by 60
Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis
Flume, P. A., Clancy, J. P., Retsch‐Bogart, G. Z., et al. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.05.001 · Cited by 59
Pourhajibagher, M., Boluki, E., Chiniforush, N., Pourakbari, B., Farshadzadeh, Z., Ghorbanzadeh, R., Azimzadeh, M., & Bahador, A. (2016) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2016.07.007 · Cited by 59
Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa
Sabaeifard, P., Ali, A. A., Soudi, M. R., Gamazo, C., & Irache, J. M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.049 · Cited by 59
Creech, C. B., Frenck, R. W., Sheldon, E. A., Seiden, D., Kankam, M. K., Zito, E. T., Girgenti, D., Severs, J. M., Immermann, F. W., McNeil, L. K., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.032 · Cited by 59
Moon, K. H., Weber, B. S., & Feldman, M. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-17 · Cited by 59
Rosen, T., Albareda, N., Rosenberg, N., Alonso, F. G., Roth, S., Zsolt, I., & Hebert, A. A. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.1103 · Cited by 59
Xu, Z., Gao, Y., Meng, S., Yang, B., Pang, L., Wang, C., & Liu, T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00242 · Cited by 58
Self-citationMOCAN, L. C., MATEA, C. T., Tăbăran, F., Moșteanu, O., Pop, T., Puia, I. C., Agoşton-Coldea, L., Gonciar, D., Kalman, E., Zaharie, G. C., et al. (2016) · Scientific Reports · doi:10.1038/srep39466 · Cited by 58
Saderi, H., & Owlia, P. (2015) · Europe PMC (PubMed Central) · Cited by 57
Sherman, M. P., Sherman, J., Arcinue, R., & Niklas, V. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.074 · Cited by 57
Pilus biogenesis of Gram‐positive bacteria: Roles of sortases and implications for assembly
Khare, B., & Narayana, S. V. L. (2017) · Protein Science · doi:10.1002/pro.3191 · Cited by 57
Legese, H., Kahsay, A. G., Kahsay, A., Araya, T., Adhanom, G., Saravanan, M., & Wasihun, A. G. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3353-2 · Cited by 57
Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
AbdelKhalek, A., Abutaleb, N. S., Mohammad, H. T., & Seleem, M. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199710 · Cited by 57
Galdadas, I., Lovera, S., Pérez‐Hernández, G., Barnes, M. D., Healy, J., Afsharikho, H., Woodford, N., Bonomo, R. A., Gervasio, F. L., & Haider, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31176-0 · Cited by 57
Ozenoxacin: a review of preclinical and clinical efficacy
Vilà, J., Hebert, A. A., Torrelo, A., López, Y., Tato, M., García-Castillo, M., & Cantón, R. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1573671 · Cited by 56
Kratochvil, M. J., Tal‐Gan, Y., Yang, T., Blackwell, H. E., & Lynn, D. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00313 · Cited by 55
Barceló, C. T., Franzon, B., Vasse, M., & Hochberg, M. (2016) · Evolutionary Applications · doi:10.1111/eva.12364 · Cited by 55
Winkler, K., Simon, C., Finke, M., Bleses, K., Birke, M., Szentmáry, N., Hüttenberger, D., Eppig, T., Stachon, T., Langenbucher, A., et al. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.07.007 · Cited by 55
Fauconnier, A. (2017) · EMBO Reports · doi:10.15252/embr.201643250 · Cited by 55
Antibacterial Activity of Kalanchoe mortagei and K. fedtschenkoi Against ESKAPE Pathogens
Richwagen, N., Lyles, J. T., Dale, B., & Quave, C. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00067 · Cited by 55
What Can We Learn from a Metagenomic Analysis of a Georgian Bacteriophage Cocktail?
Zschach, H., Joensen, K., Lindhard, B., Lund, O., Goderdzishvili, M., Chkonia, I., Jgenti, G., Kvatadze, N., Alavidze, Z., Kutter, E. M., et al. (2015) · Viruses · doi:10.3390/v7122958 · Cited by 54
Safaei, H. G., Moghim, S., Bahram, N. E., Fazeli, H., Poursina, F., Yadegari, S., Nasirmoghadas, P., & Nodoushan, S. H. (2017) · Advanced Biomedical Research · doi:10.4103/abr.abr_239_16 · Cited by 54
People use less information than they think to make up their minds
Klein, N., & O’Brien, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805327115 · Cited by 54
Design of a Potent Antibiotic Peptide Based on the Active Region of Human Defensin 5
Wang, C., Shen, M., Gohain, N., Tolbert, W. D., Chen, F., Zhang, N., Yang, K., Wang, A., Su, Y., Cheng, T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501824a · Cited by 53
Self-citationAntimicrobial nanomaterials against biofilms: an alternative strategy
Liu, C., Guo, J., Yan, X., Tang, Y., Mazumder, A., Wu, S., & Liang, Y. (2016) · Environmental Reviews · doi:10.1139/er-2016-0046 · Cited by 53
Azithromycin in Labor Lowers Clinical Infections in Mothers and Newborns: A Double-Blind Trial
Oluwalana, C., Camara, B., Bottomley, C., Goodier, S., Bojang, A., Kampmann, B., Ceesay, S., D’Alessandro, U., & Roca, A. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2281 · Cited by 53
Kibdelomycin Is a Bactericidal Broad-Spectrum Aerobic Antibacterial Agent
Singh, S. B., Dayananth, P., Balibar, C. J., Garlisi, C. G., Lu, J., Kishii, R., Takei, M., Fukuda, Y., Ha, S., & Young, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00382-15 · Cited by 52
Delafloxacin: A New Anti–methicillin-resistant Staphylococcus aureus Fluoroquinolone
Saravolatz, L. D., & Stein, G. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy600 · Cited by 52
Disarming the virulence arsenal of Pseudomonas aeruginosa by blocking two-component system signaling
Goswami, M., Espinasse, A., & Carlson, E. E. (2018) · Chemical Science · doi:10.1039/c8sc02496k · Cited by 51
Ramos, J. R., Gordón, M., Villarreal, E., Frasquet, J., Sánchez, M. Á., Cerezuela, M. M., Castellanos, Á., & Ramírez, P. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0484-8 · Cited by 51
Rapid killing of bacteria by a new type of photosensitizer
Zhang, Y., Zheng, K., Chen, Z., Chen, J., Hu, P., Cai, L.-R., Iqbal, Z. M., & Huang, M. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8133-8 · Cited by 50
Self-citationAdvances in macrocyclic peptide-based antibiotics
Luther, A., Bisang, C., & Obrecht, D. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.006 · Cited by 48
Chen, C., Deslouches, B., Montelaro, R. C., & Di, Y. P. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.029 · Cited by 48
Mandell, J. B., Deslouches, B., Montelaro, R. C., Shanks, R. M. Q., Doi, Y., & Urish, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-17780-6 · Cited by 48
Yuan, X., Liu, T., Wu, D., & Wan, Q. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s163979 · Cited by 47
Self-citationRodvold, K. A., Gotfried, M. H., Chugh, R., Gupta, M., Patel, A. M., Chavan, R. P., Yeole, R. D., Friedland, H. D., & Bhatia, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00682-18 · Cited by 47
Li, M., Mai, B., Wang, A., Gao, Y., Wang, X., Liu, X., Song, S., Liu, Q., Wei, S., & Wang, P. (2017) · RSC Advances · doi:10.1039/c7ra06073d · Cited by 46
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-18 · Cited by 46
Zhao, Y., Lu, Z., Dai, X., Wei, X., Yu, Y., Chen, X., Zhang, X., & Li, C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00600 · Cited by 46
Navrátilová, A., Nešuta, O., Vančatová, I., Čížek, A., Varela-M, R. E., López‐Abán, J., Villa-Pulgarín, J. A., Mollinedo, F., Muro, A., Žemličková, H., et al. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1103755 · Cited by 45
Analogues of Pseudomonas aeruginosa signalling molecules to tackle infections
Muimhneacháin, E. Ó., Reen, F. J., O’Gara, F., & McGlacken, G. P. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02395b · Cited by 45
Phages of life – the path to pharma
Forde, A., & Hill, C. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14106 · Cited by 45
Phages & Antibiotic Resistance: Are the Most Abundant Entities on Earth Ready for a Comeback?
Hill, C., Mills, S., & Ross, R. P. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0261 · Cited by 45
A Novel Alkaliphilic Streptomyces Inhibits ESKAPE Pathogens
Terra, L., Dyson, P. J., Hitchings, M. D., Thomas, L., Abdelhameed, A., Banat, I. M., Gazze, S. A., Vujaklija, D., Facey, P. D., Francis, L. W., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02458 · Cited by 45
Khan, M. H., Unnikrishnan, S., & Ramalingam, K. (2018) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2018.12.004 · Cited by 45
Exploring the potential of boronic acids as inhibitors of OXA‐24/40 β‐lactamase
Werner, J. P., Mitchell, J. M., Taracila, M. A., Bonomo, R. A., & Powers, R. A. (2016) · Protein Science · doi:10.1002/pro.3100 · Cited by 44
Yang, M., Chang, K., Chen, L.-Y., Wang, P.-C., Chou, C.-C., Wu, Z.-B., & Hu, A. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.02.003 · Cited by 43
Mendes, R. E., Castanheira, M., Woosley, L. N., Stone, G. G., Bradford, P. A., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02447-16 · Cited by 42
Rodulfo, H., Arcia, A., Hernández, A., Michelli, E., Martínez, D., Guzmán, M., Sharma, A. K., & Donato, M. D. (2019) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201961020 · Cited by 42
Nemonoxacin: First Global Approval
Poole, R. M. (2014) · Drugs · doi:10.1007/s40265-014-0270-0 · Cited by 41
How to stratify patients at risk for resistant bugs in skin and soft tissue infections?
Guillamet, C. V., & Kollef, M. H. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000244 · Cited by 41
Costa, R. S., Lins, M. O., Hyaric, M. L., Barros, T. F., & Velozo, E. S. (2016) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2016.11.001 · Cited by 41
Witek, K., Nasim, M. J., Bischoff, M., Gaupp, R., Arsenyan, P., Vasiljeva, J., Marć, M. A., Olejarz‐Maciej, A., Latacz, G., Kieć‐Kononowicz, K., et al. (2017) · Molecules · doi:10.3390/molecules22122174 · Cited by 41
Wagenlehner, F., Nowicki, M. P., Bentley, C., Lückermann, M., Wohlert, S., Fischer, C., Vente, A., Naber, K. G., & Dalhoff, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02317-17 · Cited by 40
Bai, Y.-M., Mao, J., Li, D.-X., Luo, X.-J., Chen, J., Tay, F. R., & Niu, L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.037 · Cited by 40
Self-citationKibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities
Singh, S. B., GOETZ, M. A., Smith, S. K., Zink, D. L., Polishook, J. D., Onishi, R., Salowe, S. P., Wiltsie, J., Allocco, J., SIGMUND, J. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.071 · Cited by 39
Zafar, N., Shahzadi, S., Nazir, J., Sharif, R., Rafique, M., Hassan, J. U., Shabbir, S. A., & Khalid, H. (2016) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2016.05.009 · Cited by 39
Cutrona, N., Gillard, K., Ulrich, R. J., Seemann, M., Miller, H. B., & Blackledge, M. S. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00096 · Cited by 39
Bueno, J. (2016) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000281 · Cited by 38
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone
Cho, J. C., Crotty, M. P., White, B. P., & Worley, M. V. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2050 · Cited by 38
Brunati, C., Thomsen, T. T., Gaspari, E., Maffioli, S. I., Sosio, M., Jabes, D. L., Løbner‐Olesen, A., & Donadio, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx395 · Cited by 38
Liew, S. M., Rajasekaram, G., Puthucheary, S. D., & Chua, K. H. (2019) · PeerJ · doi:10.7717/peerj.6217 · Cited by 38
Mun, S., Lee, Y., Han, S., Lee, S., Cha, S.-W., Kim, S.-B., Seo, Y., Kong, R., Kang, D.-H., Shin, D.-W., et al. (2015) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2014.1923 · Cited by 36
Erratum for Algburi et al., Control of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00165-17 · Cited by 36
Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa
Hubble, V. B., Hubbard, B. A., Minrovic, B. M., Melander, R. J., & Melander, C. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00288 · Cited by 36
Yang, D., Ho, Y. X., Cowell, L. M., Jilani, I., Foster, S. J., & Prince, L. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00045 · Cited by 36
Rosengren, H., Heal, C. F., & Büttner, P. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020213 · Cited by 35
Halaji, M., Rezaei, A., Zalipoor, M., & Faghri, J. (2018) · Oman Medical Journal · doi:10.5001/omj.2018.07 · Cited by 35
Aghraz, A., Benameur, Q., Gervasi, T., Dra, L. A., Ben-Mahdi, M. H., Larhsini, M., Markouk, M., & Cicero, N. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.13007 · Cited by 35
de Kraker, M. E. A., Sommer, H., de Velde, F., Gravestock, I., Weiss, E., McAleenan, A., Nikolakopoulos, S., Amit, O., Ashton, T., Beyersmann, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy516 · Cited by 35
Nanodelivery strategies for the treatment of multidrug‐resistant bacterial infections
Jiang, L., Lin, J. Y., Taggart, C. C., Bengoechea, J. A., & Scott, C. J. (2018) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.48 · Cited by 35
Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors
Kang, J. S., Zhang, A. L., Faheem, M., Zhang, C. J., Ai, N., Buynak, J. D., Welsh, W. J., & Oelschlaeger, P. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00133 · Cited by 34
Control of Multidrug-Resistant Gene Flow in the Environment Through Bacteriophage Intervention
Parmar, K. M., Hathi, Z. J., & Dafale, N. A. (2016) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-016-2265-7 · Cited by 33
Capilato, J. N., Philippi, S., Reardon, T., McConnell, A., Oliver, D. C., Warren, A., Adams, J. S., Wu, C. F., & Perez, L. J. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.10.021 · Cited by 33
McCool, R., Gould, I. M., Eales, J., Barata, T., Arber, M. R., Fleetwood, K. J., Glanville, J., & Kauf, T. L. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2100-3 · Cited by 33
Cited by
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y.-Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 502
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Self-citationOptimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Ferreira, R. L., da Silva, B. C. M., Rezende, G. S., Nakamura-Silva, R., Pitondo-Silva, A., Campanini, E. B., Brito, M. C. A., da Silva, E. M. L., Freire, C. C. D. M., Cunha, A. F. D., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03198 · Cited by 257
Metadata
- Authors
- Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-12-05
- Volume
- 7
- Issue
- 1
- Pages
- 1901872-1901872
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W2992929975
- Cited by
- 314
- References
- 455
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.